The National Health Surveillance Agency (Anvisa) reported that, on Monday, 28, a meeting was held with technicians from the agency and the Butantan Institute to discuss the Butanvac vaccine against covid-19. According to the agency, the clinical research protocol is already approved, but there is still a lack of specific data to start the tests in humans.
In a note, the regulatory body states that the purpose of the meeting was to evaluate the information already presented by Butantan. “But for the vaccine to start being applied to human beings, it is necessary to present specific data, which are still being generated by Butantan”, he says. According to Anvisa, an example of the missing data refers to the inactivation of the virus used in the vaccine.
Read Also
- A baby needs the most expensive medicine in the world and his parents ask the president of Ecuador for help Jun 2, 2022
- Called potentially hazardous aromatic means Apr 20, 2020
- Covid, Oxford: “With Delta variant impossible herd immunity” Aug 11, 2021
- In Ukraine officially kicked off IFA-antibody testing COVID-19 May 21, 2020
- UeD: “Call a doctor”. Tina cares about Gemma – Curler Sep 20, 2021
- India is bringing free Wi-Fi to more than 1,000 villages this year Apr 21, 2021
- Crisis in Argentina due to the pandemic: the figures left by the worst month in the country | Video Jun 2, 2021